Lewiston, Maine (Dekabr 5, 2016) Yeni İngiltərə Davalar (NEF) returns to the Androscoggin Bank Colisee on Fevral 11, 2017 növbəti qarışıq döyüş-arts hadisə, “NEF 27: RESURGENCE.” Bu gün, the fight promotion announced the addition of a professional featherweight bout to the card. Josh “Bağlayın” Harvey (2-0) görüşəcək Richie Collingham (3-3) 145-manat döyüş çəkisi.
Harvey is a former NEF MMA Amateur Lightweight Champion. O, pro çevirdi 2016 after a stellar amateur career that saw him amass a record of 5-1 while facing some of the best the region has to offer. In his pro debut, Harvey submitted Matt Denning (3-4) in Lewiston last spring. He would follow up that victory with a win over Zenon Herrera (0-5) Avqust ayında. Harvey, Bangordakı Young MMA -nın üzvüdür, Maine.
“I’m training for the fight I want, and this opponent is just one more step closer to where I am going,” said Harvey of the upcoming bout with Collingham. “Wishing him a healthy training camp and that he shows up.”
When Richie Collingham steps foot in the NEF cage on Fevral 11 it will have been nearly a decade since his last fight. Now training out of Lakes Region Vale Tudo in New Hampshire, Collingham has not actively competed since 2007. He was very active on the California MMA circuit at that time and put together a string of submission victories.
“I’m very excited about stepping into the cage with a tough fighter like Josh Harvey and fighting for NEF and putting on a good show for everyone,” said Collingham. “I’m putting in hard work and February 11th can’t come soon enough.”
NEF’s next event, “NEF 27: RESURGENCE” yer tutur Şənbə, Fevral 11, 2017 at 7 dək. Biletlər da başlayacaq $25 və indi satılır www.TheColisee.com və ya Colisee kassa axtararaq 207.783.2009, extension 525.
Hadisə və mübarizə kart yenilikləri haqqında daha ətraflı məlumat üçün, enmənin veb səhifəsinə müraciət edin www.NewEnglandFights.com. Əlavə, Siz NEF video izləyə bilərsiniz www.youtube.com/NEFMMA, follow them on Twitter @nefights and join the official Facebook group “New England Davalar."